Mylan Pays for Medicaid Fraud

Pharma companies are not doing well keeping their unscrupulous behavior quiet.

Martin Shkreli’s high profile trial for increasing the price of the drug Daraprim from $13.5 to $750 per pill, and the complicated jury selection process, is making headlines.

Now, the company Mylan – known for jacking up the price of the Epi Pen – came to a settlement with the US Justice Department to the tune of $465 million dollars.

Source: Mylan Pays – Sort Of – For Greed And Medicaid Fraud / ACSH.org

Leave a Reply

Your email address will not be published.